Dysregulation of the Th17/IL-17A response represents a fundamental pathogenic mechanism in neurological and cerebrovascular diseases, promoting neuroinflammation through infiltration into the CNS, microglial activation, and disruption of the blood–brain barrier. The gene discussed is IL17A; the disease is cerebrovascular disorder.